Praxis Precision Medicines
Biotechnology, 99 High St, Boston, Massachusetts, 02110, United States, 51-200 Employees
Phone Number: 61********
Who is PRAXIS PRECISION MEDICINES
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized ...
Read More
-
Headquarters: 99 High St, Boston, Massachusetts, 02110, United States
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 561110 |
Show More
Does something look wrong? Fix it. | View contact records from PRAXIS PRECISION MEDICINES
Praxis Precision Medicines Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Praxis Precision Medicines
Answer: Praxis Precision Medicines's headquarters are located at 99 High St, Boston, Massachusetts, 02110, United States
Answer: Praxis Precision Medicines's phone number is 61********
Answer: Praxis Precision Medicines's official website is https://praxismedicines.com
Answer: Praxis Precision Medicines's revenue is $50 Million to $100 Million
Answer: Praxis Precision Medicines's SIC: 2834
Answer: Praxis Precision Medicines's NAICS: 561110
Answer: Praxis Precision Medicines has 51-200 employees
Answer: Praxis Precision Medicines is in Biotechnology
Answer: Praxis Precision Medicines contact info: Phone number: 61******** Website: https://praxismedicines.com
Answer: Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis is applying insights into the genetic mutations that drive excitation-inhibition imbalance in diseases to select biological targets for rare and more prevalent neurological disorders. We share a common vision of reshaping the human condition into a more freeing and fulfilled existence by developing high impact medicines for patients and families affected by and living with complex brain disorders. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, CerebrumTM, and antisense oligonucleotide (ASO) platform, SolidusTM, using our understanding of shared biological targets and circuits in the brain.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month